Centessa Pharmaceuticals PLC ADR share price logo

Centessa Pharmaceuticals PLC ADR

NASDAQ: CNTA

Mid Cap

$39.66

-0.04

(-0.10%)

as on

Centessa Pharmaceuticals PLC ADR Stock Performance

as on May 6, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $39.62
    $39.84
    downward going graph

    0.10%

    Downside

    0.45%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $10.95
    $40.26
    downward going graph

    72.39%

    Downside

    1.51%

    Upside

    downward going graph

Centessa Pharmaceuticals PLC ADR share price movements today

Previous Close
$39.70
Open
$39.80
Volume
764.6K
Day's Low - High
$39.62 - $39.84
52 Week Low - High
$10.95 - $40.26

Centessa Pharmaceuticals PLC ADR Historical Returns

1 Month Return
0 %
3 Month Return
+ 68.88 %
1 Year Return
+ 230.31 %
3 Year Return
+ 745.84 %
5 Year Return
0 %

Centessa Pharmaceuticals PLC ADR Stock Fundamentals & Key Indicators

Check Centessa Pharmaceuticals PLC ADR market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.1B

EPS (TTM)

-1.7267

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-207.4M

Revenue (TTM)

15.0M

Profit Margin

0.00%

Return On Equity TTM

-42.55%

Centessa Pharmaceuticals PLC ADR vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Centessa Pharmaceuticals PLC ADR with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$6.1BNANA0.00%
BUY$40.2B127.94%75.8512.55%
BUY$107.9B99.08%25.1832.94%
NA$33.1BNA120.445.37%
BUY$73.6B40.83%17.1329.65%

Stock Returns calculator for Centessa Pharmaceuticals PLC ADR Stock including INR - Dollar returns

The Centessa Pharmaceuticals PLC ADR stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Centessa Pharmaceuticals PLC ADR investment value today

Current value as on today

₹3,70,636

Returns

₹2,70,636

(+270.64%)

Returns from Centessa Pharmaceuticals PLC ADR Stock

₹2,30,225 (+230.22%)

Dollar Impact

₹40,411 (+40.41%)

Analyst Recommendation on Centessa Pharmaceuticals PLC ADR Stock

Based on 11 analysts

BUY

81.82%

Buy

18.18%

Hold

0.00%

Sell

Based on 11 analysts, 81.82% of analysts recommend a 'BUY' rating for Centessa Pharmaceuticals PLC ADR. Average target price of $44.57

Centessa Pharmaceuticals PLC ADR Share Price Target

Get share price movements and forecasts by analysts on Centessa Pharmaceuticals PLC ADR.

What analysts predicted

11.02%UPSIDE

Target Price

$44.57

Current Price

$39.66

Analyzed by

11 Analysts

Target

$44.57

Centessa Pharmaceuticals PLC ADR target price $44.57, a slight upside of 11.02% compared to current price of $39.66. According to 11 analysts rating.

Centessa Pharmaceuticals PLC ADR Stock’s Investor Sentiment and Interest

Search interest for Centessa Pharmaceuticals PLC ADR Stock has decreased by -76% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-76% versus previous 30 day period

Centessa Pharmaceuticals PLC ADR Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
6
-
-
-
0
15
-
-
-
Gross Profit
0
6
0
0
0
0
15
0
-
-
Operating Income
-40
-35
-36
-43
-46
-74
-30
-54
-53
-68
EBITDA
-38
-32
-34
-40
-39
-107
-21
-46
-51
-87
Interest Expense
2
2
2
2
2
2
2
2
2
2
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-41
-35
-37
-43
-41
-110
-24
-49
-54
-66
Income Tax Expense
-2
1
0
0
0
1
1
0
0
0
Net Income
-38
-36
-38
-43
-42
-111
-26
-50
-54
-66
Net Profit Margin
0.00%
-537.53%
0.00%
0.00%
0.00%
-11691.13%
-174.23%
0.00%
0.00%
0.00%

Centessa Pharmaceuticals PLC ADR Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
6
-
15
Gross Profit
-
-
0
6
0
15
Operating Income
-5
-10
-212
-171
-201
-207
EBITDA
-5
-10
-209
-165
-221
-207
Interest Expense
0
0
7
9
10
11
Depreciation
0
-
0
0
0
0
Income Before Tax
-5
-10
-216
-176
-232
-195
Income Tax Expense
0
0
0
-25
2
1
Net Income
-5
-10
-216
-151
-235
-197
Net Profit Margin
0.00%
0.00%
0.00%
-2204.65%
0.00%
-1316.88%

Centessa Pharmaceuticals PLC ADR Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-37
-38
-38
-42
-111
-26
-50
-54
-66
Operating Cash Flow
-31
-37
-37
-21
-42
-57
-22
-58
-55
Investing Cash Flow
-18
16
-
44
25
-222
-39
61
-218
Financing Cash Flow
6
10
10
245
2
3
1
3
283
Change in Cash
-43
-9
-9
267
-11
-278
-60
6
11

Centessa Pharmaceuticals PLC ADR Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-10
-381
-216
-151
-235
-197
Operating Cash Flow
-10
-136
-200
-160
-142
-193
Investing Cash Flow
63
63
0
-127
31
-418
Financing Cash Flow
1
660
0
21
364
291
Change in Cash
-9
590
-201
-265
255
-321

Global Institutional Holdings in Centessa Pharmaceuticals PLC ADR

Funds
Holdings
Adage Capital Partners Gp LLC
7.29%
T. Rowe Price Associates, Inc.
3.11%
Index Venture Life Associates VI Ltd
6.44%
FMR Inc
5.79%
Point72 Asset Management, L.P.
1.93%

Centessa Pharmaceuticals PLC ADR News & Key Events

  • img

    Today's Timeline - 01 April

    Wed, 07:36 PM

    -

    Eli Lilly announces acquisition of Centessa Pharmaceuticals for $38 per share, totaling approximately $6.3 billion.

Insights on Centessa Pharmaceuticals PLC ADR

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, CNTA has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, CNTA stock has moved up by 68.9%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, CNTA has outperformed top 5 stocks with highest market-cap in its industry

About Centessa Pharmaceuticals PLC ADR

Centessa Pharmaceuticals plc, together with its subsidiaries, discovers, develops, and delivers orexin-based neuroscience therapeutics in the United Kingdom and the United States. The company develops ORX750, an orexin receptor 2 agonist, which is in Phase IIa clinical trial for the treatment of central disorders of hypersomnolence, including narcolepsy type 1 and 2, as well as idiopathic hypersomnia. It also engages in the development of ORX142 which is in Phase I clinical trial for the treatment of neurological and neurodegenerative disorders; ORX489 which is in Phase I clinical trial for the treatment of neuropsychiatric disorders; and LockBody, an early-stage immuno-oncology program technology platform. The company was incorporated in 2020 and is headquartered in Altrincham, the United Kingdom.
OrganisationCentessa Pharmaceuticals PLC ADR
Headquarters1 Ashley Road, Altrincham, United Kingdom, WA14 2DT
IndustryBiotechnology
CEODr. Mario Alberto Accardi Ph.D.
E-voting on sharesClick here to vote

Key Management of Centessa Pharmaceuticals PLC ADR

Name

Title

Mr. John J. Crowley CPA

Chief Financial Officer

Dr. Mario Alberto Accardi Ph.D.

CEO & Director

Mr. Raphael Deferiere CPA

Chief Accounting Officer

Ms. Tia L. Bush

Chief Technology & Quality Officer

Ms. Kristen K. Sheppard Esq., J.D.

Senior Vice President of Investor Relations & Corporate Communications

Dr. Kimberly A. McCormick Pharm.D.

Senior Vice President of Regulatory Affairs & Medical Writing

FAQs

What is Centessa Pharmaceuticals PLC ADR share price today?

Centessa Pharmaceuticals PLC ADR share price today is $39.66 as on at the close of the market. Centessa Pharmaceuticals PLC ADR share today touched a day high of $39.84 and a low of $39.62.

What is the 52 week high and 52 week low for Centessa Pharmaceuticals PLC ADR share?

Centessa Pharmaceuticals PLC ADR share touched a 52 week high of $40.26 on and a 52 week low of $10.95 on . Centessa Pharmaceuticals PLC ADR stock price today i.e. is closed at $39.66,which is 1.49% down from its 52 week high and 262.19% up from its 52 week low.

What is Centessa Pharmaceuticals PLC ADR's market capitalisation today?

Centessa Pharmaceuticals PLC ADR market capitalisation is $0.01T as on .

How to invest in Centessa Pharmaceuticals PLC ADR Stock (CNTA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Centessa Pharmaceuticals PLC ADR on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Centessa Pharmaceuticals PLC ADR Shares that will get you 0.0378 shares as per Centessa Pharmaceuticals PLC ADR share price of $39.66 per share as on May 6, 2026 at 1:29 am IST.

What is the minimum amount required to buy Centessa Pharmaceuticals PLC ADR Stock (CNTA) from India?

Indian investors can start investing in Centessa Pharmaceuticals PLC ADR (CNTA) shares with as little as ₹94.61 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.10 in Centessa Pharmaceuticals PLC ADR stock (as per the Rupee-Dollar exchange rate as on ). Based on Centessa Pharmaceuticals PLC ADR share’s latest price of $39.66 as on May 6, 2026 at 1:29 am IST, you will get 0.2521 shares of Centessa Pharmaceuticals PLC ADR. Learn more about fractional shares .